Mired in Controversy, Pfizer denies ties with Sprinklr on Kerala COVID-19 data deal
The Kerala government has faced criticism for allegedly compromising with the privacy of the quarantined people.
Thiruvananthapuram: Global pharmaceutical major Pfizer on Tuesday denied that it has partnered with Sprinklr to support the provision of any COVID-19 patient information from India.
The clarification came after Pfizer was dragged into a controversy surrounding the Kerala government''s deal with the US-based tech firm Sprinklr to handle data compiled from people who are quarantined due to the COVID-19 crisis.
The Kerala government has faced criticism for allegedly compromising with the privacy of the quarantined people.
Following news surfacing about the relations of Pfizer with Sprinklr, a Congress leader, here on Monday, had demanded a CBI probe into the deal.
"Pfizer has reviewed news reports on access to COVID-19 patient data appearing in certain sections of the media and has found these to be entirely baseless," the company said in a statement.
"We have not partnered with Sprinklr to support the provision of any COVID-19 patient information from India. We use Sprinklr''s platform to manage content on our social media channels," the company said.
Sprinklr is a leading customer and citizen experience management (CXM) platform that helps organisations reach, engage and listen to customers across social channels, messaging channels, forums, blogs and review sites.
Read also: Delhi High Court grants Pfizer temporary relief on cough syrup ban
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.